Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodies. 2023

Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan.

BACKGROUND It is widely known that there is low striatal 123 I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3- fluoropropyl) nortropane (123 I-FP-CIT) dopamine transporter single photon emission tomography (DaT-SPECT) uptake in patients with dementia with Lewy bodies (DLB). No studies to date have analyzed the association between longitudinal changes of clinical features and DaT uptake in patients with Parkinson syndrome, particularly those with DLB. The aim of this study was to investigate the association between the longitudinal changes in DaT uptake and the severity of parkinsonism and cognitive function in DLB patients. METHODS A total of 35 outpatients with probable DLB who underwent DaT-SPECT twice (at the initial examination and the follow-up period) in the Memory Disorder Clinic at the Department of Geriatric Medicine, Tokyo Medical University, were enrolled in this study between April 2014 and September 2020. The correlation between annual changes in DaT uptake and clinical features (cognitive function decline and parkinsonism) of the patients was analyzed. RESULTS A significant correlation was detected between annual changes in parkinsonism symptom severity and DaT uptake in the left posterior putamen (r = -0.39, P = 0.03), and between Mini-Mental State Examination scores and DaT uptake in all regions except the right posterior putamen (P < 0.05) in patients with DLB. CONCLUSIONS Our results suggested that the pathway from the ventrolateral tier of the substantia nigra to the putamen might be more crucial for motor function than other pathways, not only in Parkinson's disease but also in DLB.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D050483 Dopamine Plasma Membrane Transport Proteins Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS. Dopamine Plasma Membrane Transporter Proteins,Neurotransmitter Transport Proteins, Dopamine-Specific,Neurotransmitter Transporters, Dopamine-Specific,DAT Dopamine Transporter,DAT Dopamine Transporter Proteins,Dopamine Carriers,Dopamine Transporter,Dopamine Transporter Proteins,Dopamine Uptake Complex,SLC6A3 Protein,Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein,Carriers, Dopamine,Dopamine Transporter, DAT,Dopamine-Specific Neurotransmitter Transporters,Neurotransmitter Transport Proteins, Dopamine Specific,Neurotransmitter Transporters, Dopamine Specific,Protein, SLC6A3,Transporter Proteins, Dopamine,Transporter, DAT Dopamine,Transporter, Dopamine,Transporters, Dopamine-Specific Neurotransmitter
D020961 Lewy Body Disease A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124) Dementia, Lewy Body,Diffuse Lewy Body Disease,Cortical Lewy Body Disease,Lewy Body Dementia,Lewy Body Disease, Cortical,Lewy Body Disease, Diffuse,Lewy Body Type Senile Dementia

Related Publications

Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
August 2023, Journal of the neurological sciences,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
March 2020, Neurology,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
June 2023, NPJ Parkinson's disease,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
October 2001, European journal of nuclear medicine,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
July 2013, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
May 2004, Neurology,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
March 2020, Neurology,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
January 2016, Movement disorders : official journal of the Movement Disorder Society,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
November 2000, Neurology,
Ryo Yamamoto, and Naoto Takenoshita, and Yuta Inagawa, and Hikaru Kato, and Kyoko Kaneshiro, and Tomoki Kamiya, and Shoya Inagawa, and Aya Saisho, and Akito Tsugawa, and Yukari Mastumoto, and Mana Yoshimura, and Kazuhiro Saito, and Soichiro Shimizu, and Tomohiko Sato
July 2021, Scientific reports,
Copied contents to your clipboard!